IP Library Granted Patent US 12,349,930
Granted Patent B2
US 12,349,930 · App. 17/659,601 · Granted Jul 8, 2025

Retrieval systems and methods for use thereof

Inventors: Brian B. Martin (Santa Cruz, CA); Martin S. Dieck (Campbell, CA)
Assignee: Covidien LP
A61B17/221A61B2017/22094A61B2017/2212A61B2017/2215
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,349,930
App. No.
17/659,601
Granted
Jul 8, 2025
Kind
B2
Abstract

The devices and methods described herein relate to improved structures for removing obstructions from body lumens. Such devices have applicability in through-out the body, including clearing of blockages within the vasculature, by addressing the frictional resistance on the obstruction prior to attempting to translate and/or mobilize the obstruction within the body lumen.

Claims (26)

1. A medical device for removing an obstruction from a body passage, the medical device comprising:

at least one leading wire having a first end and a second end; and

a capturing portion having a surface extending between an open proximal end and a permeable distal end,

wherein the capturing portion is formed from the at least one leading wire such that the at least one leading wire extends through an interior of the capturing portion and diverges to form the permeable distal end, the at least one leading wire extending back in a proximal direction to form the capturing portion,

wherein the proximal end of the capturing portion is unattached proximally to another portion of the device such that the proximal end can move relative to the at least one leading wire in multiple directions, and

wherein the surface of the capturing portion comprises a translating surface and a capturing surface, each being configured so that a translating surface axial strength is greater than a capturing surface axial strength, wherein application of a tensile force on the at least one leading wire causes axial compression of the capturing surface before causing axial compression and deformation of the translating surface as the capturing portion engages the obstruction.

2. The medical device of claim 1 , where the capturing portion is formed such that articulation of the capturing portion relative to a portion of the at least one leading wire extending through the interior of the capturing portion does not cause the open, unattached proximal end to reduce in size.

3. The medical device of claim 1 , where the capturing surface is configured to generate a spring force against the translating surface when a proximal force applied by the at least one leading wire compresses the capturing surface against the translating surface when encountering resistance from the obstruction, where the capturing surface is configured to have a sufficient axial stiffness to direct the spring force and proximal force to the open, unattached proximal end as the open, unattached proximal end engages the obstruction where the capturing surface is also sufficiently flexible to conform to a shape of the body passage.

4. The medical device of claim 1 , where the capturing portion is configured so that when the open, unattached proximal end of the translating surface engages resistance equal to or greater than a threshold force, proximal movement of the at least one leading wire inverts the capturing surface within the translating surface and reduces a size of the capturing portion.

5. The medical device of claim 4 , where the capturing surface and translating surface are configured to invert upon continued proximal movement of the at least one leading wire such that the translating surface moves distally to the capturing surface.

6. The medical device of claim 1 , where the at least one leading wire is joined to a proximal bundle, where the proximal bundle comprises a stiffness greater than the at least one leading wire and where the at least one leading wire extends for a pre-determined distance from the permeable distal end to allow navigation of a distal portion of the medical device within the cerebral vasculature.

7. The medical device of claim 6 , where the pre-determined distance is at least 20 cm.

8. The medical device of claim 1 , where the capturing surface has an increased frictional resistance as compared to the translating surface, such that the capturing surface engages the obstruction for removal of the obstruction.

9. The medical device of claim 1 , where the open, unattached proximal end further comprises a plurality of flanges extending from the translating surface.

10. The medical device of claim 9 , where the flanges extend radially away from an axis of the capturing portion.

11. The medical device of claim 1 , where the capturing portion is self-expandable.

12. The medical device of claim 1 , where at least a portion of the capturing surface comprises a structure selected from the group consisting of a basket, a filter, a bag, a coil, a helical wire structure, a mesh, a single wound wire, and a plurality of crossing wires or a combination thereof.

13. The medical device of claim 1 , where the at least one leading wire includes at least a first wire and a second wire where the first and second wire each have different characteristics.

14. The medical device of claim 13 , where the characteristics are selected from a group consisting of material, cross-sectional shape, and cross-sectional size.

15. The medical device of claim 1 , where the at least one leading wire includes at least one shape memory alloy wire.

16. The medical device of claim 1 , where the at least one leading wire includes at least one wire selected from the group consisting of a superelastic wire, a polymeric wire, or a metal alloy.

17. The medical device of claim 16 , where the metal alloy comprises an alloy selected from the group consisting of stainless steel, titanium, platinum, gold, iridium, tantalum, nitinol, and combinations thereof.

18. The medical device of claim 1 , further comprising at least one radiopaque material located on the capturing portion.

19. The medical device of claim 1 , where the at least one leading wires comprises a plurality of individual wires and where one of the individual wires comprises a bundle of smaller wires.

20. The medical device of claim 1 , where the capturing portion is jointless.

21. The medical device of claim 1 , where the at least one leading wire is surrounded by a coil or coiled wire.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2022
From: LAZARUS EFFECT LLC
To: COVIDIEN LP
Reel/Frame 059729/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2022
From: MARTIN, BRIAN B.; DIECK, MARTIN S.
To: LAZARUS EFFECT, INC.
Reel/Frame 059735/0724 →
CHANGE OF NAME Recorded Apr 26, 2022
From: LAZARUS EFFECT, INC.
To: LAZARUS EFFECT LLC
Reel/Frame 059791/0694 →
Continuity (5)
Continuation 15661383 · Jul 27, 2017
Continuation 14015741 · Aug 30, 2013
Continuation 12344378 · Dec 26, 2008
Provisional Application 61016651 · Dec 26, 2007
Related Publication 20220240956A1 · Aug 4, 2022
References Cited (90)
US 8603014B2 · Alleman et al. · 2013 [cited by applicant]
US 8837800B1 · Bammer et al. · 2014 [cited by applicant]
US 9119656B2 · Bose et al. · 2015 [cited by applicant]
US 9126018B1 · Garrison · 2015 [cited by applicant]
US 9149609B2 · Ansel et al. · 2015 [cited by applicant]
US 9211132B2 · Bowman · 2015 [cited by applicant]
US 9241699B1 · Kume et al. · 2016 [cited by applicant]
US 9265512B2 · Garrison et al. · 2016 [cited by applicant]
US 9308007B2 · Cully et al. · 2016 [cited by applicant]
US 9399118B2 · Kume et al. · 2016 [cited by applicant]
US 9445828B2 · Turjman et al. · 2016 [cited by applicant]
US 9445829B2 · Brady et al. · 2016 [cited by applicant]
US 9492637B2 · Garrison et al. · 2016 [cited by applicant]
US 9539022B2 · Bowman · 2017 [cited by applicant]
US 9561345B2 · Garrison et al. · 2017 [cited by applicant]
US 9579119B2 · Cully et al. · 2017 [cited by applicant]
US 9585741B2 · Ma · 2017 [cited by applicant]
US 9642635B2 · Vale et al. · 2017 [cited by applicant]
US 9655633B2 · Leynov et al. · 2017 [cited by applicant]
US 9737318B2 · Monstadt et al. · 2017 [cited by applicant]
US 9770251B2 · Bowman et al. · 2017 [cited by applicant]
US 9801643B2 · Hansen et al. · 2017 [cited by applicant]
US 9827084B2 · Bonnette et al. · 2017 [cited by applicant]
US 9861783B2 · Garrison et al. · 2018 [cited by applicant]
US 9993257B2 · Losordo et al. · 2018 [cited by applicant]
US 10028782B2 · Orion · 2018 [cited by applicant]
US 10029008B2 · Creighton · 2018 [cited by applicant]
US 10039906B2 · Kume et al. · 2018 [cited by applicant]
US 20010044634A1 · Don et al. · 2001 [cited by applicant]
US 20010051810A1 · Dubrul et al. · 2001 [cited by applicant]
US 20020072764A1 · Sepetka et al. · 2002 [cited by applicant]
US 20050159772A1 · Lowe et al. · 2005 [cited by applicant]
US 20050192620A1 · Cully et al. · 2005 [cited by applicant]
US 20050277977A1 · Thornton · 2005 [cited by applicant]
US 20060100662A1 · Daniel et al. · 2006 [cited by applicant]
US 20070112374A1 · Paul et al. · 2007 [cited by applicant]
US 20080033845A1 · McBride et al. · 2008 [cited by applicant]
US 20080312681A1 · Ansel et al. · 2008 [cited by applicant]
US 20130030461A1 · Marks et al. · 2013 [cited by applicant]
US 20130281788A1 · Garrison · 2013 [cited by applicant]
US 20140276074A1 · Warner · 2014 [cited by applicant]
US 20140343595A1 · Monstadt et al. · 2014 [cited by applicant]
US 20150359547A1 · Vale et al. · 2015 [cited by applicant]
US 20160015402A1 · Brady et al. · 2016 [cited by applicant]
US 20160015935A1 · Chan et al. · 2016 [cited by applicant]
US 20160106448A1 · Brady et al. · 2016 [cited by applicant]
US 20160106449A1 · Brady et al. · 2016 [cited by applicant]
US 20160113663A1 · Brady et al. · 2016 [cited by applicant]
US 20160113665A1 · Brady et al. · 2016 [cited by applicant]
US 20160151618A1 · Powers et al. · 2016 [cited by applicant]
US 20160157985A1 · Vo et al. · 2016 [cited by applicant]
US 20160199620A1 · Pokorney et al. · 2016 [cited by applicant]
US 20160296690A1 · Kume et al. · 2016 [cited by applicant]
US 20160302808A1 · Loganathan et al. · 2016 [cited by applicant]
US 20160375180A1 · Anzai · 2016 [cited by applicant]
US 20170079766A1 · Wang et al. · 2017 [cited by applicant]
US 20170079767A1 · Leon-Yip · 2017 [cited by applicant]
US 20170086862A1 · Vale et al. · 2017 [cited by applicant]
US 20170100143A1 · Grandfield · 2017 [cited by applicant]
US 20170105743A1 · Vale et al. · 2017 [cited by applicant]
US 20170164963A1 · Goyal · 2017 [cited by applicant]
US 20170215902A1 · Leynov et al. · 2017 [cited by applicant]
US 20170224953A1 · Tran et al. · 2017 [cited by applicant]
US 20170281909A1 · Northrop et al. · 2017 [cited by applicant]
US 20170290599A1 · Youn et al. · 2017 [cited by applicant]
US 20180049762A1 · Seip et al. · 2018 [cited by applicant]
US 20180084982A1 · Yamashita et al. · 2018 [cited by applicant]
US 20180116717A1 · Taff et al. · 2018 [cited by applicant]
US 20180132876A1 · Zaidat · 2018 [cited by applicant]
US 20180140314A1 · Goyal et al. · 2018 [cited by applicant]
US 20180140315A1 · Bowman et al. · 2018 [cited by applicant]
US 20180140354A1 · Lam et al. · 2018 [cited by applicant]
US 20180185614A1 · Garrison et al. · 2018 [cited by applicant]
US 20220233207A1 · Martin et al. · 2022 [cited by applicant]
EP 2319575B1 · 2013 [cited by applicant]
JP 2014004219A · 2014 [cited by applicant]
JP 2018118132A · 2018 [cited by applicant]
KR 20180102877A · 2018 [cited by applicant]
WO 2008033845A2 · 2008 [cited by applicant]
WO 2015141317A1 · 2015 [cited by applicant]
WO 2017192999A1 · 2017 [cited by applicant]
WO 2018019829A1 · 2018 [cited by applicant]
WO 2018033401A1 · 2018 [cited by applicant]
WO 2018046408A2 · 2018 [cited by applicant]
WO 2018137029A1 · 2018 [cited by applicant]
WO 2018137030A1 · 2018 [cited by applicant]
WO 2018145212A1 · 2018 [cited by applicant]
WO 2018156813A1 · 2018 [cited by applicant]
WO 2018172891A1 · 2018 [cited by applicant]
WO 2018187776A1 · 2018 [cited by applicant]